Danske Bank’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.83K Hold
100
﹤0.01% 860
2026
Q1
$6.46K Sell
100
-1,200
-92% -$84.6K ﹤0.01% 877
2025
Q4
$87.5K Sell
1,300
-61,471
-98% -$4.13M ﹤0.01% 811
2025
Q3
$4.6M Sell
62,771
-26,508
-30% -$1.76M 0.01% 543
2025
Q2
$4.64M Buy
89,279
+3,821
+4% +$217K 0.01% 541
2025
Q1
$5.45M Buy
85,458
+42,069
+97% +$2.44M 0.02% 521
2024
Q4
$2.07M Sell
43,389
-28,112
-39% -$1.44M 0.01% 646
2024
Q3
$4.09M Sell
71,501
-81,181
-53% -$4.65M 0.01% 576
2024
Q2
$7.99M Buy
152,682
+37,271
+32% +$1.63M 0.03% 421
2024
Q1
$4.69M Buy
+115,411
New +$4.33M 0.01% 582

Other funds holding HALO

Danske Bank's HALO Position: Q2 2026 in Review

Danske Bank held its Halozyme (HALO) position steady in Q2 2026 at 100 shares worth $7.83K. The position accounts for ﹤0.01% of the portfolio, ranked #860.

Danske Bank first reported a position in HALO in Q1 2024 and has held it in 10 quarters since. The position peaked at $7.99M in Q2 2024. 554 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Danske Bank held 100 shares of Halozyme worth $7.83K as of Q2 2026.
  • Danske Bank left its Halozyme share count unchanged in Q2 2026.
  • Halozyme made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #860 holding.
  • Danske Bank first reported a position in Halozyme in Q1 2024 and has held it in 10 quarters since.
  • Danske Bank's Halozyme position peaked at $7.99M in Q2 2024.
  • 554 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.